Unlike most industrialized countries, the United States lacks a government health care system that negotiates prices. That may explain the price discrepancy, the researchers say.
“Many believe the government needs to play a stronger role monitoring and regulating this dysfunctional marketplace,” Dr. Hartung says. “Having healthcare professionals and professional societies speak out about this is an important first step.”
For the Neurology study, authors reported no external funding. One coauthor reported serving as a consultant for Teva Neurosciences and Biogen Idec; one coauthor reported being on the data safety monitoring committee for a Chugai Pharmaceutical clinical trial.
For the Arthritis & Rheumatology study, the authors reported no external funding or disclosures.